Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:58579-51-4
Molecular Formula:C10H8Cl3N3O
Alias
More Information
Anagrelide HCL; Agrylin; Agrelin; Thromboreductin; Xagrid; Anagrelide (Hydrochloride); Anagrelid Hydrochlorid; 6,7-Dichloro-5,10-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride; Anagrelide Hydrochloride Hydrate; Xagrid (TN); Imidazo(2,1-b)Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-3,5-Dihydro-1H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; C10H7Cl2N3O.ClH; Imidazo[2,1-b]Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; Anagrelide Hydrocholoride; C10H7Cl2N3O.HCl; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride (USP); Anagrelide Hydrochloride- Bio-X; 6,7-Dichloro-1H,2H,3H,5H-Imidazolidino[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride Anhydrous; Imidazo[2,6,7-Dichloro-1,5-Dihydro-, Monochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one HCl; 6,7-Dichloro-2H,3H,5H,10H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; 6,7-Dichloro-3,5-Dihydroimidazo[2,1-b]Quinazolin-2(1H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-.BETA.)-Quinazolin-2(3H)-ONE Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride ; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Monohydrochloride;Anagrelide Hydrochloride; Imidazo(2,1-.BETA.)Quinazolin-2(3H)-ONE, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride
Brief Introduction
Anagrelide Hydrochloride is a phosphodiesterase inhibitor with antiplatelet activity. Used as an antithrombocythemic.
CAS:827022-33-3
Molecular Formula:C26H35N7O6S
Alias
More Information
PD0332991 Isethionate; PD 0332991 Isethionate; Palbociclib (PD0332991) Isethionate; Palbociclib (Isethionate); 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethanesulfonate; 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethane-1-Sulfonate
Brief Introduction
PD 0332991 Isethionate is a selective inhibitor of cyclin dependant kinases CDK4 and CDK6 used in the treatment of cancer patients.
CAS:841205-47-8
Molecular Formula:C19H14F3N3O3
Alias
More Information
Ostarine; GTx-024; MK-2866; MK-2866(Ostarine); SARM; (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide; (S)-N-(4-Cyano-3-(Trifluoromethyl)Phenyl)-3-(4-Cyanophenoxy)-2-Hydroxy-2-Methylpropanamide; Ostarine(MK-2866); MK 2866
Brief Introduction
Ostarine (GTx-024, MK-2866) is a selective androgen receptor modulator (SARM) (selective androgen receptor modulator) with Ki of 3.8 nM, which is tissue selective for anabolic organs.
CAS:915087-33-1
Molecular Formula:C21H16F4N4O2S
Alias
More Information
Mdv 3100; Xtandi; Unii-93T0T9Gknu; [14C]-Enzalutamide; N-Methyl-4-[3-(4-Cyano-3-Trifluoromethylphenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl]-2-Fluorobenzamide; 4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluoro-N-Methylbenzamide
Brief Introduction
Enzalutamide is an oral androgen receptor antagonist. At present, it has been approved by clinical research and FDA (food and Drug Administration) for the treatment of metastatic castration tolerant prostate cancer after chemotherapy (i.e. such patients with prostate cancer whose tumor or cancer cells are still growing after chemotherapy), which can prolong the survival time of patients.
CAS:923564-51-6
Molecular Formula:C47H55ClF3N5O6S3
Alias
More Information
Navitoclax; ABT 263; ABT263; (R)-4-(4-((4'-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro-[1,1'-Biphenyl]-2-yl)Methyl)Piperazin-1-yl)-N-((4-((4-Morpholino-1-(Phenylthio)Butan-2-yl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-Morpholinyl)-1-[(Phenylthio)Methyl]Propyl]Amino]-3-[(Trifluoromethyl)Sulfonyl]Phenyl]Sulfonyl]Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethylcyclohexen-1-yl]Methyl]Piperazin-1-yl]-N-[4-[[(2R)-4-Morpholin-4-yl-1-Phenylsulfanylbutan-2-yl]Amino]-3-(Trifluoromethylsulfonyl)Phenyl]Sulfonylbenzamide; (R)-4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-enyl)Methyl)Piperazin-1-yl)-N-(4-(4-Morpholino-1-(Phenylthio)Butan-2-Ylamino)-3-(Trifluoromethylsulfonyl)p; (R)-4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-enyl)Methyl)Piperazin-1-yl)-N-(4-(4-Morpholino-1-(Phenylthio)Butan-2-Ylamino)-3-(Trifluoromethylsulfonyl)Phenylsulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-en-1-yl]Methyl}Piperazin-1-yl)-N-({4-({(1R)-3-Morpholin-4-yl-1-[(Phenylsulfanyl)Methyl]Propyl}Amino)-3-[(Trifluoromethyl)Sulfonyl]Phenyl}Sulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-En-1-Yl]Methyl}Piperazin-1-Yl)-N-[(4-{[(2r)-4-(Morpholin-4-Yl)-1-(Phenylsulfanyl)Butan-2-Yl]Amino}-3-[(Trifluoromethyl)Sulfonyl]Phenyl)Sulfonyl]Benzamide; Navitoclaxum; C47H55ClF3N5O6S3; 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-EN-1-YL)Methyl)Piperazin-1-YL)-N-((4-(((2R)-4-(Morpholin-4-YL)-1-(Phenylsulfanyl)Butan-2-YL)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; ABT-263,Navitoclax; ABT-263 In Bulk; Navitoclax, ABT-263; ABT-263 - Navitoclax; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-mo; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-Cyclohexen-1-yl]Methyl]Piperazin-1-yl]-N-[4-[[(1R)-3-Morpholino-1-(Phenylsulfanylmethyl)Propyl]Amino]-3-(Trifluoromethylsulfonyl)Phenyl]Sulfonyl-Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimet; (R)-4-(4-((4-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro-[1,1-Biphenyl]-2-yl)Methyl)Piperazin-1-yl)-N-((4-((4-Morpholino-1-(Phenylthio)Butan-2-yl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-EN-1-YL)Methyl)Piperazin-1-YL)-N-(4-(((2R)-4-(Morpholin-4-YL)-1-(Phenylsulfanyl)Butan-2-YL)Amino)-3-(Trifluoromethanesulfonyl)Benzenesulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-en-1-yl]Methyl}Piperazin-1-yl)-N-({4-({(1R)-3-(Morpholin-4-yl)-1-[(Phenylsulfanyl)Methyl]Propyl}Amino)-3-[(Trifluoromethyl)Sulfonyl]Phenyl}Sulfonyl)Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-Morpholinyl)-1-[(Phenylthio)Methyl]Propyl]Amino]-3-[(Trifluoromethyl)Sulfonyl]Phenyl]Sulfonyl]Benzamide;ABT 263;Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-dime; 4-{4-[(4'-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro[Biphenyl]-2-yl)Methyl]Piperazin-1-yl}-N-[(4-{[(2R)-4-(Morpholin-4-yl)-1-(Phenylsulfanyl)Butan-2-yl]Amino}-3-[(Trifluoromethyl)Sulfonyl]Phenyl)Sulfonyl]Benzamide; Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-YL)Methyl)-1- Piperazinyl)-N-((4-(((1R)-3-(4-Morpholinyl)-1-((Phenylthio)Methyl)Propyl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)-; Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl)Methyl)-1-Piperazinyl)-N-((4-(((1R)-3-(4-Morpholinyl)-1-((Phenylthio)Methyl)Propyl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)-; N-(4-{4-[2-(4-Chlorophenyl)-5,5-Dimethyl-Cyclohex-1-Enylmethyl]-Piperazin-1-yl}-Benzoyl)-4-((r)-3-Morpholin-4-yl-1-Phenylsulfanylmethyl-Propylamino)-3-Trifluoromethanesulfonyl-Benzenesulfonamide
Brief Introduction
ABT 263 is a new inhibitor of the anti-apoptotic BCL-2 protein; a promising new drug against cancer. It is a potent Bcl-2 family inhibitor.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!